The FDA wants to explore opportunities for premarket review efficiencies in the hopes it can “modernize and improve the review process.” The FDA hopes to inject an increased flexibility and efficiencies. For example, the agency described possibly allowing for faster and cheaper development of products that will benefit the public health. In the months ahead, the FDA said it will explore what improvements it can make within its existing, legal authorities. The goal is to make the process more efficient, transparent, predictable and efficient.
Illustration: Shutterstock